Idebenone treatment in Friedreich’s ataxia

  title={Idebenone treatment in Friedreich’s ataxia},
  author={G. Buyse and L. Mertens and G. di Salvo and I. Matthijs and F. Weidemann and B. Eyskens and W. Goossens and N. Goemans and G. Sutherland and J. V. Van Hove},
  pages={1679 - 1681}
  • G. Buyse, L. Mertens, +7 authors J. V. Van Hove
  • Published 2003
  • Medicine
  • Neurology
  • The authors report 1-year prospective data on eight patients with Friedreich ataxia. Idebenone did not halt the progression of ataxia. At the end of therapy, cardiac ultrasound demonstrated significant reduction of cardiac hypertrophy in six of eight patients. Cardiac strain and strain rate imaging showed that the reduction of hypertrophy is preceded by an early and linear improvement in cardiac function. Idebenone reduced erythrocyte protoporphyrin IX levels in five of six patients with… CONTINUE READING
    151 Citations

    Figures and Topics from this paper

    Low-dose idebenone treatment in Friedreich’s ataxia with and without cardiac hypertrophy
    • 24
    • Highly Influenced
    Patient‐reported outcomes in Friedreich’s ataxia after withdrawal from idebenone
    • 6
    • PDF
    Progress in the treatment of Friedreich ataxia.
    • 13
    Co-enzyme Q 10 and idebenone use in Friedreich ’ s ataxia
    • 12
    • PDF
    Co‐enzyme Q10 and idebenone use in Friedreich's ataxia
    • 77
    • PDF


    Idebenone in patients with Friedreich ataxia
    • 78
    Erythrocyte protoporphyrin levels in patients with Friedreich's and other ataxias.
    • 27
    • PDF
    A micromethod for free erythrocyte porphyrins: the FEP test.
    • S. Piomelli
    • Chemistry, Medicine
    • The Journal of laboratory and clinical medicine
    • 1973
    • 361